DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20222887
Published: 2022-10-28

Marchiafava-Bignami disease: an interesting case report!

Sriram Jaganathan, Medhini Rangarajan

Abstract


Marchiafava-Bignami Disease (MBD) is a rare neurodegenerative disease usually associated with chronic alcoholism characterized by demyelination and necrosis of the corpus callosum. Here, we report a 57-year-old patient who presented to our hospital with acute aphasia, disorientation and altered mental state. Diffusion weighted imaging (DWI) magnetic resonance imaging (MRI) revealed areas of restricted diffusion in the corpus callosum, bilateral periventricular white matter and right cerebellar peduncle. Given that the patient was a chronic alcoholic, a diagnosis of Marchiafava-Bignami disease was made. Supportive management with intravenous Thiamine and multivitamins was offered. The patient improved clinically after one week of treatment and a repeat DWI MRI revealed complete resolution of the abnormalities. It is imperative to diagnose MBD promptly and distinguish this from other neurological manifestations related to chronic alcoholism. An early diagnosis can aid in a better outcome and faster recovery.


Keywords


Chronic alcoholism, Corpus callosum, Demyelination, Intravenous thiamine

Full Text:

PDF

References


Fernandes LMP, Bezerra FR, Monteiro MC, Silva ML, de Oliveira FR, Lima RR, Fontes-JĂșnior EA, Maia CSF. Thiamine deficiency, oxidative metabolic pathways and ethanol-induced neurotoxicity: how poor nutrition contributes to the alcoholic syndrome, as Marchiafava-Bignami disease. Eur J Clin Nutr. 2017;71(5):580-6.

Noel L, Myers M, Kesayan T. Amantadine as a Potential Treatment for Marchiafava-Bignami Disease: Case Reports and a Possible Mechanism. Case Rep Neurol Med. 2022;4585206.

Raina S, Mahesh DM, Mahajan J, Kaushal SS, Gupta D, Dhima DS. Marchiafava-Bignami disease. J Assoc Physicians India. 2008;56:633-5.

Carrilho PE, Santos MB, Piasecki L, Jorge AC. Marchiafava-Bignami disease: a rare entity with a poor outcome. Rev Bras Ter Intensiva. 2013;25(1):68-72.

Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry. 2014;85(2):168-73.

Dong X, Bai C, Nao J. Clinical and radiological features of Marchiafava-Bignami disease. Medicine (Baltimore). 2018;97(5):e9626.

Tian TY, Pescador Ruschel MA, Park S, Liang JW. Marchiafava Bignami Disease. 2022 Apr 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022.

Celik Y, Temizoz O, Genchellac H, Cakir B, Asil T. A non-alcoholic patient with acute Marchiafava-Bignami disease associated with gynecologic malignancy: paraneoplastic Marchiafava-Bignami disease? Clin Neurol Neurosurg. 2007;109(6):505-8.

Arbelaez A, Pajon A, Castillo M. Acute Marchiafava-Bignami disease: MR findings in two patients. Am J Neuroradiol. 2003;24(10):1955-7.

Rusche-Skolarus LE, Lucey BP, Vo KD, Snider BJ. Transient encephalopathy in a postoperative non-alcoholic female with Marchiafava-Bignami disease. Clin Neurol Neurosurg. 2007;109(8):713-5.

Brion S. Marchiafava-Bignami disease. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: North Holland Publishing Company. 1977;317.

Hlaihel C, Gonnaud PM, Champin S, Rousset H, Tran-Minh VA, Cotton F. Diffusion-weighted magnetic resonance imaging in Marchiafava-Bignami disease: follow-up studies. Neuroradiology. 2005;47(7):520-4.

Kakkar C, Prakashini K, Polnaya A. Acute Marchiafava-Bignami disease: clinical and serial MRI correlation. BMJ Case Rep. 2014;502-4.

Lee SH, Kim SS, Kim SH, et al. Acute Marchiafava-Bignami disease with selective involvement of the precentral cortex and splenium: a serial magnetic resonance imaging study. Neurologist. 2011;17:213-7.